EUPRAXIA PHARMACEUTICALS INC. Retained Earnings
EUPRAXIA PHARMACEUTICALS INC. (EPRX) had Retained Earnings of -$169.58 million as of 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-03-13
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$169.58M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$131.00M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$105.50M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$77.28M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-12-31 | -$169.58M 40-F · filed 2026-03-13 |
| 2024-12-31 | -$131.00M 40-F · filed 2026-03-13 |
| 2023-12-31 | -$105.50M 40-F · filed 2025-03-20 |
| 2022-12-31 | -$77.28M 40-F · filed 2024-04-01 |